Compound Evidence File
#EC-2026-0649
TB-500 FRAG
Filed under Peptides. The bureau holds 95 laboratory returns for this compound from 35 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
35 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Feb 2026 | 10 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Nov 2025 | 2 Mar 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 6 May 2026 | 17 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Jun 2026 | 6 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Jan 2026 | 6 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Dec 2025 | 6 Jun 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 | 24 Apr 2025 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 21 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Mar 2026 | 8 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Nov 2025 | 3 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 9.9 | 3 Nov 2025 | 6 Mar 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Dec 2025 | 21 Feb 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Jun 2026 | 24 Jun 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 9.7 | 9.7 | 9.7 | 16 Mar 2025 | 16 Mar 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.7 | 7.6 | 9.8 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.6 | 7.9 | 9.5 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.6 | 8.0 | 9.2 | 23 May 2026 | 23 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.5 | 8.5 | 8.5 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 1 | 8.5 | 8.5 | 8.5 | 7 May 2025 | 7 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.3 | 8.1 | 8.6 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.2 | 7.2 | 9.0 | 24 May 2026 | 24 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 6 | 8.2 | 7.0 | 10.0 | 28 Mar 2025 | 21 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 7.5 | 7.5 | 7.5 | 20 Jun 2025 | 20 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 | 16 Mar 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 6.9 | 5.3 | 8.5 | 7 May 2025 | 24 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 | 11 Jun 2025 |
| SRY LabsCASE #VI-2026-0657 | X | 2 | 6.4 | 6.3 | 6.5 | 13 Feb 2025 | 23 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 5.9 | 5.9 | 5.9 | 25 Apr 2025 | 25 Apr 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.1 | 4.1 | 4.1 | 11 Jun 2025 | 11 Jun 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 1.8 | 1.8 | 1.8 | 2 Jul 2025 | 2 Jul 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 1.6 | 1.6 | 1.6 | 24 Apr 2025 | 24 Apr 2025 |
Open any subject to view the batch-level evidence for TB-500 FRAG alone.